The HIV/AIDS response as we knew it is over: Where do we go from here?
Looking to 2030 and beyond, the strategy to end HIV should include expanded access to long-acting ART and PrEP, sustained investments in HIV vaccine and cure research, and robust monitoring and evaluation systems. Achieving epidemic control-and ultimately ending the HIV pandemic-will require not only biomedical tools but also political will, community leadership and equitable financing. The lessons of the past underscore that sustained progress is possible, but only if we meet this moment with urgency, imagination and solidarity.
Authors
- Deeks Steve
- Jirair Ratevosian (ORCID: https://orcid.org/0000-0003-4451-4188)
- Tom Carpino
- Glenda Gray
- Chris Beyrer
- Nora E. Rosenberg
- Huub C. Gelderblom
- Patrick S. Sullivan
Institutions
- South African Medical Research Council (ZA)
- Emory University (US)
- University of California, San Francisco (US)
- University of the Witwatersrand (ZA)
- Fred Hutch Cancer Center (US)
- Duke Institute for Health Innovation (US)
Publication Details
- Journal
- Journal of the International AIDS Society
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/jia2.70077
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00